Characteristics of chronic ulcer patients by gender and ulcer aetiology from a multidisciplinary wound centre.


Journal

International wound journal
ISSN: 1742-481X
Titre abrégé: Int Wound J
Pays: England
ID NLM: 101230907

Informations de publication

Date de publication:
Aug 2024
Historique:
revised: 16 07 2024
received: 20 05 2024
accepted: 16 07 2024
medline: 7 8 2024
pubmed: 7 8 2024
entrez: 7 8 2024
Statut: ppublish

Résumé

Chronic ulcer patients form a heterogenous group of patients with various medical backgrounds. Cost-effective targeted treatment necessitates more knowledge about specific features related to different subgroups of ulcer patients. Hence, this study aimed to characterize ulcer patients according to gender and ulcer aetiology. A total of 946 consecutively recorded chronic ulcer patients in the Tampere Wound Registry (TWR) were included and data were gathered from the TWR and patient medical records. Comparisons were made between males and females and patients with venous-, arterial or mixed-, diabetic foot-, pressure- and atypical ulcers. Male patients were found to have diabetes, hypercholesterolemia and obesity significantly more often than females (59.2% vs. 39.6%; p < 0.001, 46.5% vs. 33.3%; p = 0.001, 42.7% vs. 35.9%; p = 0.017 respectively), whereas autoimmune diseases were more common among females (30.6% vs. 15.6%; p < 0.001). Recurrence of ulcers was most common among patients with venous ulcers (p < 0.001) and multimorbidity among those with diabetic foot ulcers (p < 0.001). To conclude, males with chronic ulcers would benefit particularly from lifestyle advice, multidisciplinary treatment should be targeted specifically at those with diabetic and arterial or mixed ulcers and preventive measures at those with venous ulcers.

Identifiants

pubmed: 39107919
doi: 10.1111/iwj.70012
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e70012

Subventions

Organisme : Tays
ID : 9X061
Organisme : Tays
ID : 9AC033
Organisme : Tays
ID : MK326
Organisme : Tays
ID : MJ006M

Informations de copyright

© 2024 The Author(s). International Wound Journal published by Medicalhelplines.com Inc and John Wiley & Sons Ltd.

Références

Körber A, Klode J, Al‐Benna S, et al. Etiology of chronic leg ulcers in 31,619 patients in Germany analyzed by an expert survey. J Dtsch Dermatol Ges. 2011;9(2):116‐121.
Forssgren A, Nelzén O. Changes in the aetiological spectrum of leg ulcers after a broad‐scale intervention in a defined geographical population in Sweden. Eur J Vasc Endovasc Surg. 2012;44(5):498‐503.
Apollonio A, Antignani PL, Di Salvo M, et al. A large Italian observational multicentre study on vascular ulcers of the lower limbs (Studio Ulcere Vascolari). Int Wound J. 2016;13(1):27‐34.
Hall J, Buckley HL, Lamb KA, et al. Point prevalence of complex wounds in a defined United Kingdom population. Wound Rep Reg. 2014;22(6):694‐700.
Ahmajärvi KM, Isoherranen KM, Mäkelä A, Venermo M. A change in the prevalence and the etiological factors of chronic wounds in Helsinki metropolitan area during 2008‐2016. Int Wound J. 2019;16(2):522‐526.
Isoherranen K, O'Brien JJ, Barker J, et al. Atypical wounds. Best clinical practice and challenges. J Wound Care. 2019;28(6):1‐92.
Jockenhöfer F, Gollnick H, Herberger K, et al. Aetiology, comorbidities and cofactors of chronic leg ulcers: retrospective evaluation of 1 000 patients from 10 specialised dermatological wound care centers in Germany. Int Wound J. 2016;13(5):821‐828.
Kelly M, Gethin G. Prevalence of chronic illness and risk factors for chronic illness among patients with venous leg ulceration: a cross‐sectional study. Int J Low Extrem Wounds. 2019;18(3):301‐308.
Moffatt CJ, Franks PJ, Doherty DC, Martin R, Blewett R, Ross F. Prevalence of leg ulceration in a London population. Q J Med. 2004;97(7):431‐437.
Weir GR, Smart H, van Marle J, Cronje FJ. Arterial disease ulcers, part 1: clinical diagnosis and investigation. Adv Skin Wound Care. 2014;27(9):421‐428.
Jenkins DA, Mohamed S, Taylor JK, Peek N, van der Veer SN. Potential prognostic factors for delayed healing of common, non‐traumatic skin ulcers: a scoping review. Int Wound J. 2019;16(3):800‐812.
Persoon A, Heinen MM, van der Vleuten CJM, de Rooij MJ, van de Kerkhof PCM, Achterberg T. Leg ulcers: a review of their impact on daily life. J Clin Nurs. 2004;13(3):341‐354.
Herber OR, Schnepp W, Rieger MA. A systematic review on the impact of leg ulceration on patients' quality of life. Health Qual Life Outcomes 2007;5 44. doi:10.1186/1477‐7525‐5‐44.
Nussbaum SR, Carter MJ, Fife CE, et al. An economic evaluation of the impact, cost, and Medicare policy implications of chronic nonhealing wounds. Value Health. 2018;21(1):27‐32.
Olsson M, Järbrink K, Divakar U, et al. The humanistic and economic burden of chronic wounds: a systematic review. Wound Repair Regen. 2019;27(1):114‐125.
Salenius JE, Suntila M, Ahti T, et al. Long‐term mortality among patients with chronic ulcers. Acta Derm Venerol. 2021;101(5):adv00455. doi:10.2340/00015555‐3803
Moore Z, Butcher G, Corbett LQ, McGuiness W, Snyder RJ, van Acker K. Exploring the concept of a team approach to wound care: managing wounds as a team. J Wound Care. 2014;23(Suppl 5b):S1‐S38.
Laakso M, Honkasalo M, Kiiski J, et al. Re‐organizing inpatient care saves legs in patients with diabetic foot infections. Diabetes Res Clin Pract. 2017;125:39‐46.
Pöyry A, Kimpimäki T, Kaartinen I, Salmi T. Quality registry improves the data of chronic ulcers: validation of Tampere Wound Registry. Int Wound J. 2023;20:3750‐3759. doi:10.1111/iwj.14270
Zhou J‐Q, Huang L‐F, Lu Y‐C, et al. Prevalence and prognosis of hard‐to‐heal wounds with comorbidities in China. J Wound Care. 2022;31:S7‐S15.
Ingelfinger JR, Jarcho JA. Increase in the incidence of diabetes and its implications. N Engl J Med. 2017;376(15):1473‐1474.
Shanmugam VK, Angra D, Rahimi H, McNish S. Vasculitic and autoimmune wounds. J Vasc Surg Venous Lymphat Disord. 2017;5(2):280‐292.
Moffatt CJ, Doherty DC, Smithdale R, Franks PJ. Clinical predictors of leg ulcer healing. Br J Dermatol. 2010;162(1):51‐58.
Weller CD, Bouguettay A, Team V, Flegg J, Kasza J, Jayathilake C. Associations between patient, treatment, or wound‐level factors and venous leg ulcer healing: wound characteristics are the key factors in determining healing outcomes. Wound Repair Regen. 2020;28(2):211‐218.
Margolis DJ, Knauss J, Bilker W. Medical conditions associated with venous leg ulcers. Br J Dermatol. 2004;150(2):267‐273.
Bergan JJ, Schmid‐Schönbein GW, Coleridge Smith PD, Nicolaides AN, Boisseau MR, Eklof B. Chronic venous disease. N Engl J Med. 2006;355(5):488‐498.
Kirsner RS, Vivas AC. Lower‐extremity ulcers: diagnosis and management. Br J Dermatol. 2015;73(2):379‐390.
Rocha MNB, Serna Gonzalez CV, Borges EL, Santos VLCG, Rabeh SAN, Nogueira PC. Incidence of recurrent venous ulcer in patients treated at an outpatient clinic: historical cohort. Int J Low Extrem Wounds. 2022;21:153473462110659. doi:10.1177/15347346211065929
Abbade LP, Lastória S, de Almeida RH. Venous ulcer: clinical characteristics and risk factors. Int J Dermatol. 2011;50(4):405‐411.
Dalal A, Eskin‐Schwartz M, Mimouni D, et al. Interventions for the prevention of recurrent erysipelas and cellulitis. Cochrane Database Syst Rev. 2017;6(6):1‐58.
Webb E, Neeman T, Bowden FJ, Gaida J, Mumford V, Bissett B. Compression therapy to prevent recurrent cellulitis of the leg. N Engl J Med. 2020;383(7):630‐639.
Matsushita K, Ballew SH, Coresh J, et al. Chronic kidney disease prognosis consortium. Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta‐analysis of individual participant data. Lancet Diabetes Endocrinol. 2017;15(9):718‐728.
Alavi A, Sibbald RG, Dieter Mayer D, et al. Diabetic foot ulcers: part II. Management. J Am Acad Dermatol. 2014;70(1):21.e1‐21.e46.
Atkin L, Bućko Z, Conde Montero E, et al. Implementing TIMERS: the race against hard‐to‐heal wounds. J Wound Care. 2019;28(Sup3a):S1‐S50.

Auteurs

Katarina Kuikko (K)

Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.

Teea Salmi (T)

Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Department of Dermatology, Tampere University Hospital, Tampere, Finland.

Heini Huhtala (H)

Faculty of Social Sciences, Tampere University, Tampere, Finland.

Teija Kimpimäki (T)

Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Department of Dermatology, Tampere University Hospital, Tampere, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH